Castle Biosciences Stock Forecast - Naive Prediction

CSTL Stock  USD 30.44  0.13  0.43%   
The Naive Prediction forecasted value of Castle Biosciences on the next trading day is expected to be 32.54 with a mean absolute deviation of 0.88 and the sum of the absolute errors of 53.39. Castle Stock Forecast is based on your current time horizon. Although Castle Biosciences' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Castle Biosciences' systematic risk associated with finding meaningful patterns of Castle Biosciences fundamentals over time.
  
At this time, Castle Biosciences' Inventory Turnover is quite stable compared to the past year. Asset Turnover is expected to rise to 0.63 this year, although the value of Payables Turnover will most likely fall to 3.88. . The value of Common Stock Shares Outstanding is expected to slide to about 19.8 M. Net Loss is expected to rise to about (57.4 M) this year.

Castle Biosciences Cash Forecast

To forecast cash or other financial indicators, analysts must employ diverse statistical methods, techniques, and algorithms. This approach allows them to detect underlying patterns in the Castle Biosciences' financial statements, predicting their influence on future market prices.
 
Cash  
First Reported
2018-03-31
Previous Quarter
85.6 M
Current Value
95 M
Quarterly Volatility
130.3 M
 
Covid
A naive forecasting model for Castle Biosciences is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Castle Biosciences value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Castle Biosciences Naive Prediction Price Forecast For the 29th of November

Given 90 days horizon, the Naive Prediction forecasted value of Castle Biosciences on the next trading day is expected to be 32.54 with a mean absolute deviation of 0.88, mean absolute percentage error of 1.23, and the sum of the absolute errors of 53.39.
Please note that although there have been many attempts to predict Castle Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Castle Biosciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Castle Biosciences Stock Forecast Pattern

Backtest Castle BiosciencesCastle Biosciences Price PredictionBuy or Sell Advice 

Castle Biosciences Forecasted Value

In the context of forecasting Castle Biosciences' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Castle Biosciences' downside and upside margins for the forecasting period are 29.30 and 35.77, respectively. We have considered Castle Biosciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
30.44
32.54
Expected Value
35.77
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Castle Biosciences stock data series using in forecasting. Note that when a statistical model is used to represent Castle Biosciences stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria118.3203
BiasArithmetic mean of the errors None
MADMean absolute deviation0.8752
MAPEMean absolute percentage error0.0282
SAESum of the absolute errors53.3869
This model is not at all useful as a medium-long range forecasting tool of Castle Biosciences. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Castle Biosciences. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Castle Biosciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Castle Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Castle Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
27.1030.3633.62
Details
Intrinsic
Valuation
LowRealHigh
26.1929.4532.71
Details
9 Analysts
Consensus
LowTargetHigh
30.0333.0036.63
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.060.090.14
Details

Other Forecasting Options for Castle Biosciences

For every potential investor in Castle, whether a beginner or expert, Castle Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Castle Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Castle. Basic forecasting techniques help filter out the noise by identifying Castle Biosciences' price trends.

View Castle Biosciences Related Equities

 Risk & Return  Correlation

Castle Biosciences Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Castle Biosciences' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Castle Biosciences' current price.

Castle Biosciences Market Strength Events

Market strength indicators help investors to evaluate how Castle Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Castle Biosciences shares will generate the highest return on investment. By undertsting and applying Castle Biosciences stock market strength indicators, traders can identify Castle Biosciences entry and exit signals to maximize returns.

Castle Biosciences Risk Indicators

The analysis of Castle Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Castle Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting castle stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Castle Biosciences is a strong investment it is important to analyze Castle Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Castle Biosciences' future performance. For an informed investment choice regarding Castle Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Castle Biosciences to cross-verify your projections.
For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. If investors know Castle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Castle Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.93)
Earnings Share
0.21
Revenue Per Share
11.34
Quarterly Revenue Growth
0.395
Return On Assets
(0)
The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Castle Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Castle Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Castle Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.